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Orexin/hypocretin neurons have a crucial role in the regulation of sleep andwakefulness. To help determine how these neurons promote
wakefulness, we generated transgenic mice in which orexin neurons expressed halorhodopsin (orexin/Halo mice), an orange light-
activated neuronal silencer. Slice patch-clamp recordings of orexin neurons that expressed halorhodopsin demonstrated that orange
light photic illumination immediately hyperpolarized membrane potential and inhibited orexin neuron discharge in proportion to
illumination intensity. Acute silencing of orexin neurons in vivo during the day (the inactive period) induced synchronization of the
electroencephalogram and a reduction in amplitude of the electromyogram that is characteristic of slow-wave sleep (SWS). In contrast,
orexin neuron photoinhibition was ineffective during the night (active period). Acute photoinhibition of orexin neurons during the day
in orexin/Halomice also reduced discharge of neurons in an orexin terminal field, the dorsal raphe (DR) nucleus. However, serotonergic
DR neurons exhibited normal discharge rates in mice lacking orexin neurons. Thus, although usually highly dependent on orexin
neuronal activity, serotonergic DR neuronal activity can be regulated appropriately in the chronic absence of orexin input. Together,
these results demonstrate that acute inhibition of orexin neurons results in time-of-day-dependent induction of SWS and in reduced
firing rate of neurons in an efferent projection site thought to be involved in arousal state regulation. The results presented here advance
our understanding of the role of orexin neurons in the regulation of sleep/wakefulness and may be relevant to the mechanisms that
underlie symptom progression in narcolepsy.
Introduction
Orexins/hypocretins are neuropeptides expressed in a specific pop-
ulation of neurons in the lateral hypothalamic area (LHA) (de Lecea
et al., 1998; Sakurai et al., 1998). Animals that lack these peptides,
orexin neurons, or functional orexin-2 receptors show phenotypes
similar to that of the sleep disorder narcolepsy (Chemelli et al., 1999;
Lin et al., 1999; Hara et al., 2001; Willie et al., 2003), that is, sleep/
wakefulness fragmentation and cataplexy. The onset of human nar-
colepsy usually occurs after adolescence. The most common initial
symptom is excessive daytime sleepiness (EDS), followed by cata-
plexy and hallucinations (Okun et al., 2002; Morrish et al., 2004;
Ohayonet al., 2005). Thepathophysiologyof narcolepsy is related to
orexin deficiency (Peyron et al., 2000; Thannickal et al., 2000). In-
deed, central administration of orexin induces wakefulness and de-
creases slow-wave sleep (SWS) and rapid eye movement (REM)
sleep durations (Hagan et al., 1999; Piper et al., 2000). Orexin neu-
rons fire phasically during active wakefulness (AW) and are silent
during SWS (Lee et al., 2005;Mileykovskiy et al., 2005). These find-
ings indicate that the orexin system has a critical role in the regula-
tion of sleep/wakefulness, especially in the maintenance of arousal.
Orexin neurons densely innervate the monoaminergic nuclei
that are implicated in the regulation of sleep/wakefulness, includ-
ing the dorsal raphe nucleus (DR), locus ceruleus (LC), and tu-
beromammillary nucleus (TMN) (Peyron et al., 1998; Sakurai et
al., 1998; Horvath et al., 1999; Nambu et al., 1999; Bayer et al.,
2001; Yamanaka et al., 2002; Sakurai, 2007). Orexin innervates
and activates DR neurons (Brown et al., 2001, 2002), and, con-
versely, orexin neurons are innervated by serotonergic neurons
and inhibited by serotonin (Muraki et al., 2004; Sakurai et al.,
2005). Although this reciprocal neural circuit has been proposed
to stabilize the distribution of sleep/wakefulness in a coordinated
manner, how orexin neuronal activity influences sleep/wakeful-
ness is incompletely understood.
To address this issue, we have created a transgenic mouse in
which the orange light-activated neuronal silencer halorhodopsin
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(Halo) (Han and Boyden, 2007; Zhang et al., 2007), is expressed in
orexin neurons, and we acutely inactivated these neurons in vitro
and in vivo. Optogenetics using the light-activated neuronal activa-
tor channelrhodopsin-2 has been used previously to explore orexin
neuron function (Adamantidis et al., 2007; Carter et al., 2009). We
find that illumination of orexin neurons expressingHalo resulted
in inhibition of orexin neurons in vitro. Acute silencing of orexin
neurons in vivo induced changes in the electroencephalogram
(EEG) and electromyogram (EMG) that are characteristic of
SWS. Furthermore, during silencing of orexin neurons in vivo,
serotonergic DR neuron activity decreased to levels observed
during SWS, indicating a loss of excitatory drive associated with
inactivation of orexin neurons. However, in orexin/ataxin-3
mice, the activity of DR neurons was indistinguishable from that
of wild-type mice, suggesting that compensatory regulation oc-
curs in the chronic absence of orexin input.
Materials andMethods
Animal usage. All experimental procedures involving animals were ap-
proved by the National Institute for Physiological Sciences Animal Care
and Use Committee and were in accordance with NIH guidelines. All
efforts were made to minimize animal suffering or discomfort and to
reduce the number of animals used.
Generation of orexin/Halo transgenic mice. The transgenic construct
was made by substituting the nLacZ gene (SalI–BamHI fragment) of the
orexin/nLacZ transgenic construct (Sakurai et al., 1999) with the 1.6 kb
Halo fragment (Han and Boyden, 2007), which is expressed as a fusion
protein with enhanced green fluorescent protein (EGFP). The transgene
was excised and microinjected into pronuclei of fertilized mouse eggs
(BDF1 mice) to generate transgenic founders. Founders were bred with
BDF1 mice to produce stable orexin/Halo transgenic lines. A total of 13
transgene-positive founders were obtained in the orexin/Halo transgenic
mice. Analysis of the N1 generation demonstrated that only three lines
(lines 5, 7, and 8) showed a sufficiently strong expression ofHalo. Among
these lines, line 5 was used for subsequent experiments because this line
showed the highest expression rate (94% of orexin neurons).
Brain slice preparation. Male and female orexin/EGFP (Yamanaka et
al., 2003a,b) and orexin/Halo transgenic mice (3–4 weeks old) were used
for whole-cell recordings. The mice were deeply anesthetized with iso-
flurane (Abbott Japan) and decapitated. Brains were quickly isolated in
ice-cold cutting solution consisting of the following: 280 mM sucrose, 2
mM KCl, 10 mM HEPES, 0.5 mM CaCl2, 10 mM MgCl2, and 10 mM glu-
cose, pH 7.4 with NaOH, bubbled with 100% O2. Brains were cut coro-
nally into 350 m slices with a microtome (VTA-1200S; Leica). Slices
containing the LHA were transferred to an incubation chamber filled
with physiological solution containing the following: 135mMNaCl, 5mM
KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, and 10 mM glucose, pH
7.4 with NaOH, bubbled with 100% O2 and incubated for at least 1 h at
room temperature (RT) (24–26°C).
In vitro electrophysiological recordings. At RT, the slices were trans-
ferred to a recording chamber (RC-27L; Warner Instruments) on a flu-
orescence microscope stage (BX51WI; Olympus). Neurons that had
EGFP fluorescence were identified as orexin neurons and were subjected
to electrophysiological recordings. The fluorescence microscope was
equipped with an infrared camera (C2741-79; Hamamatsu Photonics)
for infrared differential interference contrast imaging and a cooled
charge-coupled device (CCD) camera (Cascade 650; Roper Scientific) for
fluorescent imaging. Each image was displayed separately on a monitor
and saved on a computer. Recordings were performed with an Axopatch
200B amplifier (Molecular Devices) using a borosilicate pipette (GC150-
10; Harvard Apparatus) prepared by a micropipette puller (P-97; Sutter
Instruments), filled with intracellular solution (4–6 M) consisting of
the following (in mM): 138 K-gluconate, 10 HEPES, 8 NaCl, 0.2 EGTA-
Na3, 2 MgATP, and 0.5 Na2GTP, pH 7.3 with KOH. The osmolarity of
the solution was checked by a vapor pressure osmometer (model 5520;
Wescor). The osmolarity of the internal and external solutions was 280–
290 and 320–330mOsm/L, respectively. The liquid junction potential of
the patch pipette and perfused extracellular solution was estimated to be
16 mV and was corrected in the data. Recording pipettes were under
positive pressure while advancing toward individual cells in the slice, and
tight seals on the order of 1.0–1.5 G were made by negative pressure.
Themembrane patch was then ruptured by suction. The series resistance
during recording was 10–25 M. The reference electrode was an Ag–
AgCl pellet immersed in bath solution. During recordings at RT, cells
were superfused with extracellular solution at a rate of 1.6 ml/min using
a peristaltic pump (Dynamax; Rainin).
Orange or blue light was generated by a xenon lamp (75 W, model
UXL-75XB; Olympus) by passing through an FF01-586/20-25 filter
(586  10 nm; Semrock) or FF01-472/30-25 filter (472  15 nm; Sem-
rock), respectively, controlled by a filter changer (Lambda 10-2; Sutter
Instruments) via MetaFluor 5.0.7 software (Universal Imaging). To alter
light intensity, neutral density filters (6 and 25% permeation) on the
fluorescent microscope were used.
The output signal was low-pass filtered at 5 kHz and digitized at 10
kHz. Data were recorded on a computer through a Digidata 1322A
analog-to-digital converter using pClamp software version 10.2 (Molec-
ular Devices).
Drugs. Tetrodotoxin (TTX) (Wako) was dissolved in extracellular so-
lution at a concentration of 1 M. During the experiments, TTX was
applied by bath application.
Immunohistochemical studies.Male and female orexin/Halo transgenic
mice (4 or 15 weeks old) were deeply anesthetized with isoflurane and
perfused sequentiallywith 20ml of chilled saline and 20ml of chilled 10%
Formalin solution (Wako). The brains were removed and immersed in
the above fixative solution for 24 h at 4°C and then immersed in a 30%
sucrose solution for at least 2 d. The brains were quickly frozen in em-
bedding solution (Sakura Finetechnical). For orexin and GFP double
staining, coronal sections (40 m) of orexin/Halo transgenic mouse
brains were incubated with rabbit anti-GFP antiserum (1:1000; Invitro-
gen) for 24 h at 4°C. These sections were incubated with Alexa Fluor
488-labeled anti-rabbit IgG (1:800; Invitrogen) for 1 h at RT. The sec-
tions were then incubated with guinea pig anti-orexin antiserum (1:500)
for 24 h at 4°C and incubated with Alexa Fluor 594-labeled goat anti-
guinea pig IgG (1:800; Invitrogen) for 1 h at RT. The sections were
mounted and examined with a fluorescence microscope (BZ-9000; Key-
ence) or a confocal microscope (LSM510; Carl Zeiss).
To confirm the position of implanted fiber optics, cryostat coronal
sections (50m) were stained by the avidin–biotin–peroxidase method.
Briefly, brain sections were incubated for 40 min in Tris-buffered saline
containing 0.3% H2O2 to inactivate endogenous peroxidase. Sections
were transferred into Tris-buffered saline containing 0.25% Triton
X-100 and 1% bovine serum albumin fraction V (TBS-BX) for 30 min
and then incubatedwith guinea pig anti-orexin antibody diluted 1:800 in
TBS-BX overnight at 4°C. Sections were then incubated with biotin-
labeled anti-guinea pig IgG goat antibody (Vector Laboratories) diluted
1:1000 in TBS-BX for 1 h at RT, followed by incubation with avidin and
biotinylated peroxidase complex solution for 30 min at RT. Bound per-
oxidasewas visualized by incubating sectionswith 3,3-diaminobenzidine
tetrahydrochloride (ImmPACT DAB peroxidase substrate; Vector Lab-
oratories), resulting in a golden-brown reaction product. The sections
weremounted and examined with amicroscope (BZ-9000; Keyence). To
confirm the specificity of antibodies, incubations without primary anti-
body were conducted as a negative control in each experiment, and no
signal was observed. To determine whether neuronal death occurred in
the lateral hypothalamic area subjected to photic illumination, tissue
sections containing this region were immunostained for the micro-
glial marker IbaI. For IbaI staining, brain sections were incubated
with rabbit anti-IbaI antiserum (Wako) for 24 h at 4°C. These sections
were incubated with biotin-labeled anti-rabbit IgG goat antibody
(Vector Laboratories) diluted 1:1000 in TBS-BX for 1 h at RT, fol-
lowed by incubation with avidin and biotinylated peroxidase complex
solution for 30 min at RT. Bound peroxidase was visualized by incu-
bating sections with 3,3-diaminobenzidine tetrahydrochloride in the
presence of 0.25% nickel ammonium sulfate (ImmPACT DAB perox-
idase substrate; Vector Laboratories), resulting in a black reaction
product.
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In vivo extracellular recordings. Fifteen-week-old male orexin/Halo
mice, their wild-type littermates and orexin/ataxin-3 transgenic mice
[N13 backcrossed to C57BL/6J; kindly supplied by Dr. Sakurai, Ka-
nazawa University, Kanazawa, Japan (Hara et al., 2001)] were housed
under controlled lighting (12 h light/dark cycle; lights on from 8:00 A.M.
to 8:00 P.M.) and temperature (22°C) conditions. Food and water were
available ad libitum. Mice were anesthetized with isoflurane using a va-
porizer for small animals (SF-B01; DS Pharma Biomedical) and posi-
tioned in a stereotaxic frame (David Kopf Instruments). Plastic fiber
optics (0.5 mm diameter; Eska; Mitsubishi Rayon) were bilaterally im-
planted 1 mm above the LHA (1.7 mm posterior, 1 mm lateral from
bregma, 4 mm depth). Electrodes for EEG and EMG were implanted on
the skull and neck muscle, respectively. A U-shaped plastic plate was
attached to the skull using dental cement (GC Corporation) to enable
fixation of the mouse’s head to the stereotaxic frame during extracellular
recordings. The mice were then housed separately for a recovery period
of at least 7 d.
After the 7 d recovery period, the skull (4.5 mm posterior from bregma)
was drilled under isoflurane (1%) anesthesia (SF-B01; DS Pharma Biomed-
ical) to make a window to allow subsequent insertion of a glass recording
microelectrode.Thewindowwas coveredbyanantibiotic-containing oint-
ment (tetracycline, 30 mg/g; Pfizer) to protect from drying and infection
until the day of experiment. After another 2 d recovery period,mice were
placed in a plastic box fitted to their body and then attached to the
stereotaxic frame via the U-shaped plastic plate with water provided ad
libitum. Acclimation to the stereotaxic instrument occurred for 2 d at the
same time of day (11:00A.M. to 7:00 P.M.) duringwhich the experiments
were scheduled. By the second acclimation day, all mice showed sponta-
neous sleep while in the stereotaxic frame. On the day of the experiment,
mice were mounted in the stereotaxic frame at 11:00 A.M. with water
provided ad libitum and recordings were performed between 1:00 P.M.
and 7:00 P.M.
The activity of single neuronswas recorded extracellularly using a glass
pipette microelectrode (WPI) filled with a 0.5 M sodium acetate solution
containing 2%Pontamine SkyBlue (PSB) (15–30M). The difference in
electrical potential was amplified (Intra 767;WPI), filtered, and digitized
at a sampling rate of 10 kHz (Micro1401; Cambridge Electronic Design).
A window discriminator (model 121 discriminator; WPI) was used to
isolate a specific unit from noise or the activity of other neurons. Sero-
tonergic neurons were discriminated from others using the following
criteria: (1) a longer duration of the action potential; (2) a shoulder on
the falling phase or a deflection in the negative component of action
potentials; and (3) the firing pattern during sleep/wakefulness (tonic
firing during wakefulness, decreased firing frequency during SWS, and
quiescence during REM sleep) (Takahashi et al., 2005). EEG and EMG
signals were amplified (DAM70; WPI), filtered, digitized at a sampling
rate of 200 Hz (EEG) and 100 Hz (EMG), and recorded using Spike 2
software (version 5.04; Cambridge Electronic Design).
Tomark the tip of the recording electrode by PSB labeling, current was
injected through the recording electrode (10 A for 6 min). After the
experiment, themice were decapitated and perfused sequentially with 20
ml of chilled saline and 20 ml of chilled 10% Formalin solution (Wako).
The brains were removed and immersed in the same fixative solution for
24 h at 4°C. The brains were quickly frozen in embedding solution
(Sakura Finetechnical). For counterstaining, coronal sections (50m) of
the brains of wild-type, orexin/Halo transgenic, or orexin/ataxin-3 trans-
genic mice were incubated with the reduced form of -nicotinamide-
adenine dinucleotide phosphate (-NADPH) (Oriental Yeast Co.) and
nitroblue tetrazolium (Wako) for 30 min at 37°C and then stained with
neutral red (Sigma).
In vivo photo illumination using freely moving mice. Continuous EEG
and EMG recordings were performed through a slip ring (Air Precision)
designed so that the movement of the mouse was unrestricted. EEG and
EMG signals were amplified (AB-610J; Nihon Koden), filtered (EEG,
1.5–30 Hz; EMG, 15–300Hz), digitized at a sampling rate of 128 Hz, and
recorded using SleepSign software version 3 (Kissei Comtec). Orange
light was generated by LED (590 5 nm, 1 W; OSY5XME1C1E; Opto-
Supply) and applied through plastic optical fibers bilaterally inserted 1
mm above the LHA. An optical swivel (COME2; Lucir) was used for
unrestricted in vivo photo illumination. Orange light power intensity at
the tip of the plastic fiber optics (0.5 mm diameter) was 0.4 mW/mm2
measured by power meter (VEGA; Ophir Optronics). Preliminary stud-
ies indicated that the physiological response to photic illumination sub-
sided with illumination durations longer than 1 min and could not be
replicated within the same recording session, suggesting photolysis or
internalization of the halorhodopsin protein. Accordingly, orange light
illumination was performed for 1 min durations between 1:00 P.M. and
7:00 P.M. (light period) and 9:00 P.M. and 11:00 P.M. (dark period).
Eachmouse received photic illumination fromone to three timeswith an
interval of at least 4 d between each illumination. The animal’s behavior
was monitored through a CCD video camera and recorded on a com-
puter synchronized with EEG and EMG recordings using the SleepSign
video option system (Kissei Comtec).
Behavioral state classification and EEG power spectral analyses. EEG/
EMG records were automatically scored in 4 s epochs and classified as
wakefulness, SWS, or REM sleep by SleepSign software according to
standard criteria (Tobler et al., 1997; Yamanaka et al., 2002). All vigilance
state classifications assigned by SleepSign were examined visually and
corrected if necessary. The same individual, blinded to genotype and
experimental condition, scored all EEG/EMG recordings. Spectral anal-
ysis of the EEGwas performed by fast Fourier transform (FFT) (sampled
at 128 Hz). This analysis yielded a power spectra profile over a 0–40 Hz
window with a 1 Hz resolution divided into delta (1–5 Hz), theta (6–10
Hz), alpha (10–13 Hz), and beta (13–25 Hz) waves. An average EEG
spectrum profile was calculated from EEG power densities in each fre-
quency bin and then expressed as average power values of delta, theta,
alpha, and beta waves for each state.
Statistical analysis.Data were analyzed by unpaired t test, paired t test,
and one-way or two-way ANOVA, as appropriate for the parameters
examined, using the KaleidaGraph 4.0 software (Hulinks).When appro-
priate, ANOVA tests were followed by post hoc analysis of significance
using Fisher’s protected least significant difference test. p values 0.05
were considered statistically significant.
Results
Specific expression of halorhodopsin in orexin neurons
We generated transgenic mice in which orexin neurons specifi-
cally expressed Halo under control of the human prepro-orexin
promoter (orexin/Halo transgenic mice). This 3.2 kb DNA frag-
ment allows the expression of exogenous genes in the orexin
neurons (Sakurai et al., 1999, 2005; Hara et al., 2001; Moriguchi
et al., 2002; Yamanaka et al., 2003b; Tsujino et al., 2005). The
specific expression of Halo by orexin neurons was confirmed by
double-labeled immunohistochemistry. An anti-GFP antibody
was used to detect Halo because Halo is expressed as a fusion
protein with GFP. A merged picture (GFP-IR and orexin-IR)
revealed that Halo was exclusively observed in orexin neurons
(Fig. 1). No expression of Halo was observed throughout the
brain other than in orexin neurons. GFP-IR was observed in the
soma and dendrites (Fig. 1B, arrows) of orexin neurons but not
in the axons (Fig. 1B, arrowhead). Orexin neurons expressing
Halo did not show blebbing or other features indicative of inap-
propriate trafficking (Fig. 1B). In the orexin/Halo transgenic
mice, 3 of 13 transgenic mouse lines (lines 5, 7, and 8) expressed
Halo in orexin neurons. Halo expression rate (GFP-IR/orexin-
IR 100%) of lines 5, 7, and 8 was 94.1 0.7% (n 3), 31.7
2.3% (n 3), and 85.9 3.6% (n 3), respectively. Because line
5 showed the highest expression, these mice were used for all
subsequent in vivo and in vitro experiments. The number and
morphology of orexin-IR neurons in the line 5 orexin/Halo trans-
genic mice were indistinguishable from those of wild-type mice
(data not shown).
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Membrane properties ofHalo-expressing
orexin neurons
To confirm the function of Halo expressed
in the transgenic mouse brain, slice patch-
clamp analyses were performed. First, we
testedwhether the basicmembrane proper-
ties of orexin neurons were affected by the
expression of Halo. Electrical properties of
Halo-expressing orexin neurons were com-
paredwith thoseofEGFP-expressingorexin
neurons in orexin/EGFP transgenic mice.
There were no significant differences in the
resting membrane potential, peak ampli-
tude of action potential, spontaneous firing,
input resistance, or membrane capacitance
between these strains (Table 1). Along with
the apparent normalmorphology of orexin/
haloneurons (Fig. 1B), these results indicate
that the anatomy and physiology of orexin
neuronswerenot adversely affectedbyHalo
expression in these cells.
Orange light illumination
hyperpolarizes Halo-expressing
orexin neurons
Orexin neurons were whole-cell patch
clamped and orange light (wavelength,
586 10 nm)was illuminated through an
objective lens. Orange light illumination
immediately hyperpolarized the mem-
brane potential and completely inhibited
the generation of spontaneous action po-
tentials in orexin neurons (Fig. 2A). In
contrast, neither blue (wavelength 472 
15 nm) nor orange light had an effect on
the membrane potential of orexin neu-
rons in orexin/EGFP transgenic mice; this
suggests that orange light-induced hyperpolarization was caused
by the activation of Halo (Fig. 2B). Non-orexin neurons, which
did not have GFP fluorescence, showed no response to orange or
blue light illumination in either orexin/EGFP or orexin/Halomice
(data not shown). In the presence of TTX, orange light illumina-
tion also induced hyperpolarization, suggesting a direct effect
(Fig. 2C). The magnitude of Halo-mediated hyperpolarization
depended on the light intensity (Fig. 2C). Orange light-induced
hyperpolarizations of orexin neurons were 1.8 0.2 mV [n 5,
p 0.40, not significantly different (NS)], 5.5 1.3 mV (n 5,
p 0.0061), 7.5 1.5mV (n 5, p 0.001), and 11.3 2.4mV
(n 5, p 0.001) under light intensities of 1.5, 6, 25, and 100%
(4 mW), respectively (Fig. 2D). Blue light illumination (100%
intensity) had little effect on the membrane potential of Halo-
expressing orexin neurons (2.3 0.9 mV, n 5, p 0.27, NS).
Conversely, neither blue (100% intensity) nor orange (100% in-
tensity) light affected the membrane potential of orexin neurons
in orexin/EGFP transgenic mice. The higher sensitivity of Halo to
orange light than to blue light is corroborated by previous reports
(Han and Boyden, 2007; Zhang et al., 2007). Thus, subsequent
slice patch-clamp experiments used the 100% light intensity
level. Hyperpolarizationwas also induced by short (2 s) repetitive
and longer (10 s) illumination durations (Fig. 2E,F). The hyper-
polarization levels induced by repetitive 2 s pulses of orange light
were 6.5 0.9 mV (first application, n 7, p 0.001), 6.9 0.9
mV (second application, n 7, p 0.001), 7.8 1.0 mV (third
application, n 7, p 0.001), 6.2 0.9 mV (fourth application,
n 7, p 0.001), and 4.8 0.8mV (fifth application, n 7, p
0.0015) (Fig. 2G). Although hyperpolarization gradually de-
creased with repetitive orange light illumination, it was still sig-
nificant in response to the fifth pulse.
Next, we tested the ability of Halo to enable sustained, rapidly
inducible and reversible inhibition of orexin neuronal activity.
Under current-clamp mode, a rectangular depolarizing current
(0.5 Hz, 4–15 pA, 250 ms) was injected through the recording
electrode to generate artificial action potentials. Orange light il-
lumination for 10 s completely inhibited current injection-
induced action potentials (Fig. 2H). The probability of current
injection-induced firing was normalized to the 10 s before light
illumination. Firing probability during orange light illumination
was significantly reduced to 6.7  4.6% (n  6, p  0.001) of
control levels (Fig. 2 I). Firing completely recovered after termi-
nation of orange light illumination (93.3 4.6% of control, n
Figure 1. Halo is specifically expressed in orexin neurons in the orexin/Halo transgenic mouse brain. A, Orexin-IR neurons are
located in the LHA (Alexa Fluor 594, red). GFP-IR neurons, indicatingHalo expression, are also observed in the LHA (Alexa Fluor 488,
green).Merged picture shows specific expression of Halo in orexin neurons in the LHA in the orexin/Halo transgenicmice (top row).
Scale bar, 100m.More than 90%of orexin neurons express Halo. GFP-IR is observed in the soma and dendrites. No expression of
Halo other than in orexin neuronswas observed throughout the brain. Bottom row is highermagnifications of square region in the
top row. Scale bar, 50 m. B, Confocal microscopic image of a 15-week-old orexin/Halo transgenic mouse showing that Halo
expression is observed in the soma and dendrites of orexin neurons (arrows) but not in axons (arrowhead). Scale bar, 50m.
Table 1. Electrical membrane properties of Halo-expressing orexin neurons
Halo () orexin neurons EGFP () orexin neurons
Resting membrane potential (mV) 52.8 2.1 (n 5) 52.5 1.7 (n  6)
Peak amplitude (mV) 17.3 1.6 (n 6) 13.4 3.0 (n  5)
Spontaneous firing (Hz) 4.8 1.0 (n 5) 4.7 1.0 (n  8)
Input resistance (M) 531.2 76.7 (n7) 489.3 30.2 (n12)
Membrane capacitance (pF) 27.1 1.5 (n 9) 27.2 2.0 (n 11)
Values are means SEM.
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6, p 0.19, NS). These results indicate that the activity of Halo-
expressing orexin neurons can be continuously and repeatedly
inhibited by orange light illumination.
Orange light illumination induces an outward current in
Halo-expressing orexin neurons
Under voltage-clamp mode, a significant outward current was
induced by repetitive, brief (2 s) or longer (10 s) orange light
illumination durations in Halo-expressing orexin neurons in the
presence of TTX (Fig. 3A,B). Holding membrane potential (Vm)
at60 mV, the orange light-induced outward current was 5.7
0.4 pA (n 8, p 0.001) (Fig. 3C). The current was not affected
by changing the holding potential from60 to40 or90 mV,
consistent with the belief that Halo is a chloride ion pump. The
reversal potential of chloride under the recording conditions
used was calculated as74 mV. Holding Vm at40 or90 mV,
the orange light-induced current was 5.8  0.3 pA (n  6, p 
0.001) or 5.4 0.5 pA (n 6, p 0.001), respectively (Fig. 3C).
In contrast, blue light had little effect on current in Halo-
expressing orexin neurons, which was in agreement with the
current-clamp results (1.6 0.2 pA, n 5, p 0.06, NS).
Orange light inhibits spontaneous firing in orexin neurons
Orange light-induced inhibition of orexin neurons was con-
firmed using loose cell-attached recording, whichmonitors firing
frequency without affecting the intracellular conditions of the neu-
ron being recorded in the brain slice preparation. Before light stim-
ulation,orexinneuronshada spontaneous firing rateof3.20.3Hz
(n6).Repetitive 2 s orange light illumina-
tion completely inhibited spontaneous fir-
ing inHalo-expressing orexin neurons (Fig.
4A). The firing probability during repetitive
orange light illumination significantly de-
creased to 9.0 4.8% (first response,n 6,
p 0.001), 10.4 7.4% (second response,
n 6, p 0.001), and 18.8 13.1% (third
response, n 6, p 0.001) of control levels
(Fig. 4B). Next, to determine the duration
of Halo-induced silencing, orange light was
continuously illuminated for 3 min. Loose
cell-attached recording revealed that orange
light illumination immediately inhibited
spontaneous firing. Although spontaneous
firing gradually recovered after 1 min illu-
mination, inhibition was still significant
even after 3min illumination (57.9 5.6%,
n  7, p  0.00018, paired t test vs basal
firing) (Fig. 4C,D). When illumination was
terminated, firing greatly increased but re-
turned to basal levels within 2 min. These
results strongly suggested that orange light
illuminationof thehypothalamuswould in-
hibit the activity of orexin neurons in vivo.
Based on these results, the following in vivo
experiments were performed.
In vivo orange light illumination of the
hypothalamus induces SWS inmice
during the light, but not dark, period
To study the physiological significance of
orexin neuronal activity in the regulation
of sleep/wakefulness, we performed in
vivo photic illumination of the hypothal-
amus using freely moving orexin/Halo transgenic mice. To deter-
mine the sleep/wakefulness state during recording, mice were
chronically implanted with EEG and EMG electrodes. To deliver
orange light to the hypothalamus, plastic fiber optics were bilat-
erally implanted into the brain. During the time when mice
showed spontaneous wakefulness in the late light period (1:00
P.M. to 7:00 P.M.), orange light was illuminated for 60 s through
the fiber optics from an LED light source (590 5 nm). During
orange light illumination of the hypothalamus, EEG power grad-
ually increased and EMG power gradually decreased (Fig. 5A).
Spectral analysis of the EEGwas performed by FFT on 4 s record-
ing epochs. Cortical EEG power spectra revealed that spectral
intensities, particularly that of the delta range, increased in con-
junction with orange light illumination, suggesting the induction
of SWS (Fig. 5B–F, Table 2). During the second half of the 60 s
photic illumination period, all orexin/Halo transgenic mice
showed SWS (n  7) (Fig. 5G–I). After termination of photic
illumination, the EEG showed fast waves and increased EMG
levels were observed, indicating that the mice were awake (Fig.
5A). Interestingly, after a brief period of wakefulness, mice
tended to fall asleep again without any additional photic illumi-
nation (Fig. 5A,G).
In contrast to the results described above, orange light illumi-
nation of the hypothalamus of awake, freely moving orexin/Halo
transgenic mice had no effect on the sleep/wakefulness pattern
during the dark period (9:00 P.M. to 11:00 P.M.) when nocturnal
mice have the greatest spontaneous activity and arousal level (n
10) (Fig. 5J–L). In a limited number of experiments during the
Figure2. Orange light inhibits the activity ofHalo-expressingorexinneurons.A, Underwhole-cell current-clampmode, orange
light illumination induced instantaneous hyperpolarization and completely inhibited spontaneous action potentials in Halo-
expressing orexin neurons. B, Neither blue nor orange light illumination had an effect on membrane potential or spontaneous
firing frequency in orexin neurons expressing EGFP alone in orexin/EGFPmice. C, Orange light induced hyperpolarization in a light
intensity-dependent manner in the presence of TTX. Light intensities are 1.5, 6, 25, and 100% (from left to right). D, Bar graph
summarizing the data in C (n 5). Halo () neuron, Halo-expressing orexin neurons from orexin/Halomice; Halo () neuron,
EGFP-expressing orexin neurons from orexin/EGFPmice. E, F, Brief (2 s), repetitive illumination (E) and longer (20 s), continuous
illumination (F ) induced hyperpolarization in the presence of TTX.G, Bar graph summarizing the data in E (n 7).H, Orange light
also inhibited current injection-induced action potentials. Orange light illumination for 10 s inhibited firing elicited by rectangular
current pulse injection through the recording electrode (0.5 Hz, 4 pA, 250 ms). I, The bar graph shows the firing probability
calculated from the data in H (n 6). Firing probability is normalized to 10 s before light illumination. Orange light was applied
through the objective lens, as represented by the colored bar. Values are represented asmeans SEM. *p 0.05 vs orange light
illumination of Halo () orexin neurons.
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dark period, orange light illumination occurred while mice were
in SWS, but neither wakefulness nor REM sleep resulted. Silenc-
ing of orexin neurons at either time of day did not induce an acute
transition from wakefulness to REM sleep as occurs in narcolep-
tic patients and mice.
After the experiments, immunohistochemical analyses con-
firmed that the tip of the fiber opticswas1mmabove the orexin
neuron field in the LHA (n 10) (Fig. 6). Brainswere also stained
using an anti-IbaI antibody, a marker of microglial cells that are
activated after brain injury and that remove dead neurons by
phagocytosis. Although activation of microglia was observed
near the fiber scars, no signs of activation of microglia cells were
observed in the illuminated area (i.e., the lateral hypothalamic
area). These results suggest that orange light illumination did not
induce injury in brain (data not shown).
Photic inhibition of orexin neurons reduces firing of neurons
in an orexin terminal field
To further study the physiological significance of orexin neuronal
activity in sleep/wakefulness regulation in conjunction with
other arousal-promoting nuclei, EEG/EMG and the activity of
DR neurons were simultaneously recorded using in vivo extracel-
lular recording (Fig. 7A). Serotonergic neurons in the DR are
densely innervated by orexin neurons and are directly and indi-
rectly activated by orexin (Brown et al., 2001). orexin/Halo trans-
genic mice were mounted in the stereotaxic frame via a plastic
U-shaped frame fixed onto the skull. During extracellular record-
ing, the mouse was conscious and showed spontaneous bouts of
sleep and wakefulness (see Materials and Methods). First, the
spontaneous sleep/wakefulness pattern in orexin/Halo transgenic
mice was analyzed to determine whether the presence of theHalo
transgene affected normal sleep/wakefulness regulation under
the restraint condition. Thus, we compared the sleep/wakeful-
ness episode durations and cortical EEG power spectra in orexin/
Halo transgenic mice with those of wild-type littermate mice.
Neither the episode durations nor the EEG power spectra during
the late light period (1:00 P.M. to 7:00 P.M.) differed significantly
between the two genotypes (Fig. 7C, Table 3). The average EEG
power densities in delta (1–5 Hz), theta (6–10 Hz), alpha (10–13
Hz), and beta (13–25Hz) bandwidths within each sleep/wakeful-
Figure 3. Orange light illumination induces an outward current in Halo-expressing orexin
neurons.A, Under voltage-clampmode, withmembrane potential held at60mV, brief (2 s),
repetitive orange light illumination induced an outward current in the presence of TTX. In
contrast, blue light illumination had little effect.B, Longer (10 s) illumination induced a contin-
uous outward current in the presence of TTX withmembrane potential held at60mV. C, Bar
graph summarizing blue or orange light-induced outward current under holding potentials of
40,60, or90 mV (n 5–8). Halo (), Halo-expressing orexin neurons from orexin/
Halo mice; Halo (), EGFP-expressing orexin neurons from orexin/EGFP mice. Blue or orange
light was applied through an objective lens as indicated by gray bars. Blue or orange light
application is dark gray or light gray, respectively. Values are represented as means SEM.
*p 0.05 vs Halo () neurons. Vh, Holding potential.
Figure4. Orange light illuminationblocks spontaneous firingof orexinneurons.A, In a loose
cell-attached recording fromHalo-expressingorexinneurons in vitro, brief (2 s) pulses of orange
light illumination completely inhibited spontaneous firing. Top, Spontaneous actionpotentials;
bottom, histogram of firing frequency plotted in 1 s bins. B, Bar graph summarizing the firing
probability of orexin neurons during control conditions and during 2 s periods of orange illumi-
nation (n 6). The firing probability was normalized to the spontaneous firing frequency
during the 10 s before illumination. R1, Recovery period between first and second response. R2,
Recovery period between second and third response. R3, Recovery period after third response.
C, In a loose cell-attached recording from Halo-expressing orexin neurons in vitro, continuous
illumination for 3 min also inhibited spontaneous firing. Regions indicated by bar and number
weremagnified in thebottom.D, Linegraph summarizingdata inC (n7). Basal frequency for
60 s before experiment was set as 100%. Orange light was applied through an objective lens as
indicated by the gray bar. Values are means SEM. * or filled circle, p 0.05 versus control.
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ness state were not significantly different between the two groups
either (n 13) (Fig. 7C).
The firing frequency of DR neurons was then compared be-
tweenwild-type littermates and orexin/Halo transgenicmice dur-
ing wakefulness, SWS, and REM sleep. DR neurons that were
likely to be serotonergic were identified according to previously
reported electrophysiological criteria (Takahashi et al., 2005)—a
longer duration action potential, a shoulder on the falling phase,
and/or a deflection in the negative component of action poten-
tials (Fig. 7B)—and will be referred to here as “presumably sero-
tonergic.” We found that the firing frequency of presumably
serotonergic DR neurons was not significantly different between
wild-type littermates and orexin/Halo transgenic mice in any
sleep/wakefulness stage (Fig. 7D). The firing frequencies of DR
neurons during wakefulness, SWS, and REM sleep in wild-type
mice were 2.9  0.5 Hz (n  13), 1.2  0.2 Hz (n  22), and
0.03  0.02 Hz (n  9), respectively, and those in orexin/Halo
transgenic mice were 3.3  0.5 Hz (n 
12, p  0.38, NS), 1.4  0.2 Hz (n  26,
p 0.53, NS), and 0.01 0.01 Hz (n 6,
p 0.97, NS), respectively (Fig. 7D). The
position of the recording electrode was
confirmed after each experiment by
marking the tip of the electrode using PSB
labeling (Fig. 7E). These results indicate
that neither the EEG spectral power prop-
erties nor the activity of presumably sero-
tonergic DR neurons were affected by
expression of Halo in orexin neurons.
Next, we studied the effect of acute or-
ange light inhibition of orexin neurons on
sleep/wakefulness and presumably seroto-
nergic DR neuron activity. During times
when mice showed spontaneous wakeful-
ness in the late light period (1:00 P.M. to
7:00 P.M.), the LHA was illuminated with
orange light for 60 s duration through the
fiber optics using an LED light source
(590 5 nm). During orange light illumi-
nation, EEG delta power gradually in-
creased and EMG power gradually
decreased (Fig. 7G,I,K). In addition, simul-
taneous in vivo extracellular recordings
from presumably serotonergic DR neurons
revealed that the firing frequency gradually
decreased inconjunctionwith theEEGdelta
power increase. Furthermore, DR neuron
discharge wasmarkedly reduced during the
second 30 s of illumination (Fig. 7G,J). Im-
mediately after the termination of orange
light, firing in the DR neurons quickly re-
covered to the basal wakefulness level, and
the EEG showed low amplitude, fast activ-
ity, and greater EMG levels indicative of
wakefulness (Fig. 7G,J). These results are
consistent with those observed in freely
moving orexin/Halo transgenic mice sub-
jected tophotic illumination (Fig. 5D,E). In
wild-type littermate mice, orange light illu-
mination of the hypothalamus had little ef-
fect on the EEG, EMG, or the activity of DR
neurons (Fig. 7F). The EEG power spectral
analysis by FFT showed that EEG power in
delta, theta, alpha, and beta bandswas significantly increased during
the second half of orange light illumination compared with the 30 s
before illumination (Fig. 7I), although it did not reach the same
amplitude characteristic of deepSWS that occurs 1–2min after SWS
onset (Fig. 7H). Simultaneous in vivo extracellular recording from
presumably serotonergicDRneuronsalso showedthat the firingrate
was significantly reduced (Fig. 7J). The firing rates of DR neurons
before illumination (pre), the first half illumination (0–30 s), the
second half illumination (30–60 s), and after illumination (post)
were 3.30.3Hz (n12), 2.10.2Hz (n12,p0.0041), 0.9
0.3Hz (n 12, p 0.001), and 3.2 0.3Hz (n 12, p 0.84,NS),
respectively. These results suggest that acute silencing of orexin neu-
ronal activity by illuminating orange light into the hypothalamus
decreased firing frequency of presumably serotonergic neurons in
the DR and induced SWS inmice.
To further study the effect of orexin neuronal activity on the
DR neurons, orexin/ataxin-3 transgenic mice, in which orexin
Figure 5. Acute inhibition of orexin neurons induces SWS. EEG and EMG electrodes were chronically implanted to determine
sleep/wakefulness state. Plastic fiber optics (0.5mmdiameter)were bilaterally inserted into the hypothalamus. Orange light from
an LED (590 5 nm)was applied through the fiber optics. A, Representative traces show EEG (top trace) and EMG (bottom trace)
during orange light illumination during the second half of the light period (1:00 P.M. to 7:00 P.M.). Orange light illumination was
initiated at a random time when orexin/Halo mice were awake. B, Bar graph shows EEG power spectra of each epoch (4 s)
corresponding to A. Bar graph shows a typical EEG power spectrum before illumination (C), during illumination (D, E), and after
cessation of illumination (F ). Line graphs summarize the percentage of animals showingwakefulness (G, J ), SWS (H,K ), and REM
sleep (I, L) duringorange light illumination in the light period (1:00P.M. to7:00P.M.;n7;G–I ) and in thedarkperiod (9:00P.M.
to 11:00 P.M.; n 10; J–L). The data in G–L are based on experiments in which mice had been awake at least for 8 s (2 epochs)
during either the light or dark period before orange light illumination. The orange shading indicates the period of light illumina-
tion. A total of sevenmicewere tested for in vivophotic illuminations. Thesemicewere used for photic illuminationduringboth the
light and dark periods.
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neurons are specifically ablated (Hara et al., 2001), were subjected
to extracellular recording. Orexin neurons are gradually elimi-
nated in the brains of these transgenicmice, and almost all orexin
neurons are gone by 10 weeks of age. The average EEG power
densities in delta, theta, alpha, and beta bandwidths in each sleep/
wakefulness state did not significantly differ between wild-type
mice and orexin/ataxin-3 transgenic mice (Fig. 7C). Surprisingly,
no significant differences were observed in the firing frequency of
DR neurons of orexin/ataxin-3 transgenic mice compared with
wild-type mice in any vigilance state (wakefulness, SWS, or REM
sleep). The firing frequencies of serotonergic neurons in orexin/
ataxin-3 transgenic mice during wakefulness, SWS, and REM
sleep were 3.1 0.4Hz (n 13, p 0.58, NS), 1.4 0.2Hz (n
17, p 0.56, NS), and 0.004 0.004 Hz (n 12, p 0.96, NS),
respectively (Fig. 7D). These results suggest that presumably se-
rotonergic DR neuronal activity is usually highly dependent on
orexin neuronal activity but can apparently be normally regu-
lated in the chronic absence of orexin input.
Discussion
Here, we described the first transgenic mice in which a light-
sensitive protein is chronically expressed in orexin neurons.
Acute optogenetic inhibition of orexin neurons with the orange
light-activated neuronal silencer Halo induced SWS during the
day, consistent with physiological importance for orexin neuro-
nal activity in the maintenance of arousal. Although optogenetic
activation of orexin neurons has been reported previously to in-
creasewakefulness and reduce SWSandREMsleep (Adamantidis
et al., 2007; Carter et al., 2009), the results obtained here were
unexpected for several reasons. First, orexin neurons are only
phasically active during AW, with periods of silence during both
quiet wakefulness (QW) and AW (Lee et al., 2005; Mileykovskiy
et al., 2005; Takahashi et al., 2008). Thus, there is no a priori
reason to expect that acute inhibition of these cells during the
second half of the inactive period (when QW predominates)
would result in sleep. In fact, we expected that optogenetic
inactivation would be most effective in sleep induction during
the dark period, when AW predominates and orexin neuron
firing would be greatest. In support of this prediction, orexin
antagonists have been shown to induce sleep when adminis-
tered during the dark period (Brisbare-Roch et al., 2007). Sec-
ond, the concept of the orexin system as a wake-promoting
system arose from the observation that orexin neurons degen-
erate in human narcoleptics, who have difficulty maintaining
wakefulness. However, acute optogenetic inhibition is com-
pletely different from narcolepsy, in which chronic absence of
orexin likely results in reorganization of the downstream cir-
cuitry controlling sleep/wakefulness.
Specific expression of Halo enables silencing of orexin
neuronal activity
Neuronal expression of Halo in nematodes, zebrafish, and mice
enables suppression of neural activity by orange light illumina-
tion (Han and Boyden, 2007; Zhang et al., 2007; Arrenberg et al.,
2009). Here, Halo was expressed in almost all orexin neurons
with no ectopic expression. The specific expression of Halo in
orexin neurons affected neither the morphology of these cells,
their membrane properties, nor the spectral characteristics of
sleep/wakefulness states. Neurons from transgenic mice in which
Halo is expressed under the Thy1 promoter were electrophysi-
ologically indistinguishable from other neurons (Zhao et al.,
2008), demonstrating the safety and utility of Halo in mediating
neural silencing. Although Halo and other molecules are com-
monly used in viral form in optogenetic studies, we demonstrated
here that Halo transgenic mice can be used to study behavior
in a scientifically and clinically relevant context. Whole-cell
recordings demonstrated that orange light illumination in-
duced hyperpolarization and completely inhibited spontane-
ous action potentials in Halo-expressing orexin neurons. In
addition, orange light-induced silencing of orexin neuronal
activity was observed using loose cell-attached recording, sug-
gesting that orange light illumination could inhibit the activity
of orexin neurons in vivo.
Acute silencing of orexin neurons induced SWS but only
during the day
The firing rate of orexin neurons is greatest during AW; these
cells are silent during sleep (Lee et al., 2005; Mileykovskiy et al.,
2005). Mice lacking prepro-orexin, the OX2R gene, or orexin
neurons exhibit reduced daily amounts of wakefulness (Chemelli
et al., 1999; Hara et al., 2001; Willie et al., 2003), suggesting that
the orexin system has a crucial role in the maintenance of wake-
fulness. However, how the activity of orexin neurons contributes
to wakefulness control is incompletely understood. Conse-
quently, the activity of orexin neuronswasmanipulated in vivo by
optogenetics. Orange light illumination into the hypothalamus
through implanted fiber optics induced a gradual EMG decrease
and increased EEG delta power, indicating that acute silencing of
orexin neurons in the late light period induced SWS in orexin/
Halo transgenic mice.
The EEG power spectrum in orange light-induced SWS did
not reach the amplitude characteristic of deep SWS that occurs
1–2 min after SWS onset. Halo-induced SWS may still be a tran-
sitional state, perhaps because orexin neuron inhibition did not
last 	1 or 2 min, likely as a result of desensitization of the Halo
protein. Alternatively, orange light-induced SWS may not be
identical to physiological SWS because only one arousal system
(the orexin system) is being inhibited directly.
Table 2. The average EEG power densities in the delta, theta, alpha, and beta wave
bands
Pre Orange (0–30 s) Orange (30–60 s) Post
Delta (%) 100 167.4 49.9 165.9 59.3 134.1 21.8
Theta (%) 100 113.1 22.4 113.9 22.4 68.9 10.3
Alpha (%) 100 164.0 29.0 193.3 50.0 106.2 22.6
Beta (%) 100 130.9 22.0 149.1 39.1 85.1 10.4
Total (%) 100 122.7 12.7 176.6 21.3 119.3 6.9
The average EEG power densities were normalized to the EEG during the 30 s before illumination (n 7). Pre, 30 s
before illumination; Post, 30 s after illumination; 0–30 s, the first half 30 s illumination; 30–60 s, the second half
30 s illumination. Values are represented as means SEM.
Figure 6. The location of the plastic fiber optic tip was confirmed after each experiment.
Fiber optics were bilaterally implanted in the brain 1 mm above the LHA region in which
orexin-IR neurons are located. A, Orexin-IR neurons (brown) show scattered distribution in the
LHA (brown). Scale bar, 500m. B, Higher magnification of the square region indicated in A.
Scale bar, 300 m. Dashed line indicates the position of implanted fiber optics (0.5 mm in
diameter).
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Optogenetic activation of orexin neurons through channel-
rhodopsin-2, a blue light-activated nonselective cation channel,
increased wakefulness and reduced SWS and REM sleep (Ada-
mantidis et al., 2007; Carter et al., 2009). Here, orexin neuron
inhibition promoted SWS, suggesting that activity of orexin neu-
rons is critical tomaintain arousal in the light period. In contrast,
Table 3. Episode duration of wakefulness, SWS, and REM sleep during light period
of orexin/Halo transgenic mice andwild-typemice
Wild-type mice orexin/Halomice
Wakefulness (s) 80.3 21.5 69.6 14.2
SWS (s) 81.6 10.4 79.9 9.9
REM sleep (s) 82.2 22.5 76.0 12.6
Figure 7. Acute inhibitionof orexinneurons induces SWSanddecreases theactivity of serotonergicDRneurons.A, Schematic drawingof in vivoextracellular recordings fromtheDRandphotic illumination
of the hypothalamus using fiber optics. EEG and EMG electrodeswere implanted to determine sleep/wakefulness state. Plastic fiber optics (0.5mmdiameter)were bilaterally inserted into the hypothalamus.
Orange light from LED (590 5 nm)was applied through these fibers. Firing frequency of serotonergic DR neurons was recorded through a glass electrode inserted into the DR.B, Averaged shape of spikes
classifiedaspresumablyserotonergicneurons (toptraces)andnonserotonergicneurons (bottomtraces) in theDR.SerotonergicDRneuronshave longeractionpotentialduration(1ms)aswell asadeflection
in the negative component (arrow, top left trace) or a shoulder on the falling phase (arrow, top right trace).C, Bar graph summarizing the average EEGpower density in the delta, theta, alpha, andbeta bands
during wakefulness, SWS, and REM sleep of wild-type littermate mice, orexin/Halo mice, and orexin/ataxin-3 mice during the light on period (n 13). D, Bar graph summarizes the firing frequency of
serotonergic neurons in the DR during wakefulness, SWS, and REM sleep recorded from wild-type littermate mice (n 9–22), orexin/Halomice (n 6–26), and orexin/ataxin-3mice (n 12–17). E,
Confirmationof anextracellular recording fromneurons in theDR. ThearrowshowsPSB labeling (blue), indicating the locationof the tipof the recordingelectrode (left). Scalebar, 500m.The right is ahigher
magnification of the rectangle in the left (right). Scale bar, 300m. F, G, Representative EEG/EMG recordings and firing frequency of DR neurons during orange light illumination in wild-typemice (F ) and
orexin/Halomice (G).H, Power spectral analysis of EEG recorded fromorexin/Halomice (n12). The topgraph showspower spectra of spontaneously occurringwakefulness, SWS, andREMsleepobserved in
orexin/Halomiceduringthe lights-onperiod(n6–26).Thebottomgraphshowspowerspectra:Pre,30sbefore illumination;Post,30safter illumination;0–30s, the firsthalf30s illumination;30–60s, the
secondhalf30s illuminationinorexin/Halomiceduringthelightsonperiod(n6–26). I,TheaverageEEGpowerdensities inthedelta, theta,alpha,andbetawavebands(n12).Averagepowersignificantly
increased in the secondhalf of light illumination inall four frequencybands. J, Bar graph summarizing the firing frequencyof serotonergicDRneuronsduringorange light illuminationoforexin/Halomice (n
12).K, Bar graph summarizing integrated EMG levels. Integrated EMG levelswere normalized to Pre, 30 s before illumination. Values are represented asmeans SEM. *p 0.05.
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inhibition of orexin neurons failed to induce SWS in the dark
period. Carter et al. (2009) reported similar results in that orexin
neuron-induced arousal was diminished by sleep deprivation
and at specific circadian phases. This diurnal difference in effi-
cacy might be attributable differences in sleep pressure across the
day. During the light period, homeostatic sleep pressure is rela-
tively high. At this time of day, the silencing of orexin neurons
decreased the activity of serotonergic DR neurons (and likely
other monoaminergic neurons), which would create conditions
that are permissive for the occurrence of SWS. Conversely, the
presence of neither orexin nor orexin neurons are required for
wakefulness to occur during the light period because both the
orexin ligand (Chemelli et al., 1999; Mochizuki et al., 2004) and
orexin cell knock-out (Hara et al., 2001)mice have nearly normal
levels of sleep and wake during the light period. During the dark
period, in contrast, homeostatic sleep pressure is relatively low
and inhibition of orexin neurons at this time of day might be
insufficient to induce SWS as a result of high activity of other
wake-promoting systems. Alternatively, the Halo-induced cur-
rentmight not be great enough to completely block the activity of
orexin neurons during the dark period. Because the orexin antag-
onist almorexant induces sleep during the dark period (Brisbare-
Roch et al., 2007), the latter alternative is more likely.
Acute inhibition of orexin neurons decreased firing in
DR neurons
Serotonergic DR neurons show tonic firing during wakefulness,
decreased firing during SWS, and complete silence during REM
sleep (McGinty and Harper, 1976). Our extracellular recordings
of DR neurons corroborate these conclusions. Serotonergic neu-
rons are densely innervated by orexin neurons and are directly
and indirectly activated by orexin (Nambu et al., 1999; Brown et
al., 2001). Conversely, serotonergic neurons innervate and in-
hibit orexin neurons (Muraki et al., 2004). Here, acute silencing
of orexin neurons induced a gradual decrease in the firing fre-
quency in DR serotonergic neurons to the same level as observed
in SWS. This suggests that the activity of serotonergic neurons is
highly dependent on orexin neuronal activity. Whether a similar
inhibition occurs in other orexin projection sites such as the
LC and TMN remains to be determined, particularly because
channelrhodopsin-mediated stimulation of orexin neurons
activates these nuclei (Carter et al., 2009). Interestingly, re-
bound activation of orexin neurons occurred when Halo inhi-
bition was terminated, and the firing rate of DR serotonergic
neurons also increased at this time. This rebound excitation of
orexin neurons might also activate neurons in other orexin
projection sites as well. Collectively, this rebound excitation of
orexin neurons and orexin projection sites may underlie the
wakefulness induction that occurs just after cessation of
orexin neuron photic inhibition.
We expected that the activity of serotonergic neurons in
orexin/ataxin-3mice would be reduced during wakefulness rela-
tive to wild-type mice. Surprisingly, however, serotonergic DR
neurons in orexin/ataxin-3 mice showed no differences in firing
frequency in any state compared with wild-type mice. Orexin/
ataxin-3 mice have normal serotonin levels in the forebrain
(Mori et al., 2010). These results indicate that the activity of se-
rotonergic DR neurons is normally highly influenced by orexin
neuronal activity but, in the chronic absence of orexin input,
compensation can occur.
Perspective
In narcoleptic humans, the most common initial symptom is
EDS, which is subsequently followed by other symptoms of the
narcoleptic tetrad (Okun et al., 2002; Morrish et al., 2004;
Ohayon et al., 2005).Our resultsmay be relevant to this symptom
progression. Initial dysfunction of orexin neuronswould result in
decreased excitatory drive and reduced activity of arousal-
promoting monoaminergic nuclei, thereby contributing to EDS.
As the orexin neurons degenerate, the activity of monoaminergic
neurons would likely become less dependent on orexin, perhaps
as plastic reassembly of the neuronal circuit underlying sleep/
wakefulness control occurs or through a change of themembrane
properties of the neurons involved. Although compensatory reg-
ulation of the DR neurons may occur in the chronic absence of
orexin, it apparently does not mitigate the symptomatology in
orexin/ataxin-3 mice nor, presumably, in narcoleptic humans.
These factorsmight contribute to the progression from EDS dur-
ing the initial phase of orexin neuron dysfunction to the subse-
quent symptomatology of narcolepsy, including cataplexy, when
neurodegeneration occurs.
In summary, this study provides the first example of sleep
induction via optogenetic silencing of a specific type of neuron,
because the orexin/Halo transgenicmice enabled us to control the
transition from wakefulness to SWS. Furthermore, the silencing
of orexin neurons and transition to SWS was accompanied by a
reduction in the firing rate in an efferent projection site of the
orexin neurons, the DR, a brain region that has long been impli-
cated in arousal state control.
Note added in proof. Recent work by Sasaki et al. (2011) also
indicated importance of orexin neurons in the maintenance of
arousal. They manipulated the activity of orexin neurons using a
new method called the Designer Receptors Exclusively Activated
by Designer Drugs approach (DREADD). Using this system, ex-
citation of orexin neurons significantly increased the amount of
time spent in wakefulness and decreased both REM and non-
REM sleep times. Inhibition of orexin neurons decreased wake-
fulness time and increased non-REM sleep time.
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